In the case of placement at N-terminus of synthetic anti-HER2 ZHER2:S1 affibody molecules, the use of monoamide of NOTA derivative NODAGA results in the 68Ga-labeled conjugate providing higher tumor-to-blood ratios than conjugates labeled using monoamides of DOTA and NOTA [63]. This evidence concerns the gene ERBB2 and neoplasm.